Effect of Orthokeratology on Myopia Progression in French Children
NCT ID: NCT05700240
Last Updated: 2023-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
2019-11-02
2020-12-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multi-center Study of the Effect of Orthokeratology on Myopia Progression
NCT04284111
Peripheral Relative Refractive Power of Orthokeratology Lenses
NCT07294404
Myopia Prevention With Reading Glasses
NCT05030103
Effectiveness of Orthokeratology in Myopia Control
NCT03465748
Effect of Orthokeratology Versus Spectacles on Myopia Progression in Chinese Children: A Crossover Trial
NCT02186184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orthokeratology treatment
orthokeratology
rigid contact lenses
single-vision spectacle correction
single-vision spectacle correction
simple wear of spectacle
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
orthokeratology
rigid contact lenses
single-vision spectacle correction
simple wear of spectacle
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Myopia between 0,50 D and 7.00 D
* Astigmatism ≤ 4.00 D with-the-rule 180+-20
* Anisometropia ≤ 1.50 D
* Myopia evolution ≥ 0.25 D over 6 months
* Best-corrected visual acuity (BCVA) ≥ 20/20 (Snellen equivalent)
* Follow-up period \> 6 months
Exclusion Criteria
* Contraindication for contact lens wear or orthokeratology
* Preexisting ocular (amblyopia, strabismus, ocular inflammation, trauma, or surgery) or systemic disease
* Poor compliance to lens wear, examination or follow-up
7 Years
17 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professeur Jean-Baptiste CONART
Professeur
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jean-Baptiste CONART
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022PI090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.